90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL
This study has been completed.
Sponsor:
Stanford University
Collaborators:
Biogen Idec
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00186589
First received: September 14, 2005
Last updated: June 5, 2012
Last verified: October 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | July 2007 |
| Primary Completion Date: | July 2007 (Final data collection date for primary outcome measure) |